Delivery Order SPE2DB22D2206-SPE2DB25FJK88
- Not listed
- The Defense Logistics Agency awarded a $11,053.54 firm fixed price delivery order to AmerisourceBergen Drug Corp for Xermelo 250 mg tablets (84-count) on September 11, 2025, with an ultimate completion date of October 2, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a delivery order valued at $5,526.76 to AmerisourceBergen Drug Corp for 84 tablets of Xermelo 250 mg on July 23, 2025, with completion expected by August 13, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitively awarded procurement fulfilling pharmaceutical supply requirements for military healthcare systems. The work will be performed at AmerisourceBergen's corporate headquarters in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $5,526.76 to AmerisourceBergen Drug Corp for 84 tablets of Xermelo 250 mg on August 25, 2025, with an ultimate completion date of September 16, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare...
- The Defense Logistics Agency awarded a $5,526.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Xermelo 250 mg tablets (84-count units). This non-set-aside competitive award is scheduled for completion by August 11, 2025, with performance to be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $5,526.76 to AmerisourceBergen Drug Corp for the supply of Xermelo 250 mg tablets (84-count units). This competitive award, issued on April 24, 2025, carries a firm fixed price structure with an ultimate completion date of May 15, 2025. The contract represents a non-set-aside procurement supporting federal medical supply needs through AmerisourceBergen's established distribution network based in Conshohocken, Pennsylvania. This...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency on September 11, 2025, for the supply of Xermelo 250 mg tablets (84-count units) under a firm fixed-price contract with a ceiling value of $11,053.54. The order is expected to be completed by October 2, 2025, and will be fulfilled from the vendor's corporate office in Conshohocken, Pennsylvania. This is a competitive award with no set-aside designation, reflecting AmerisourceBergen's capability to compete...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Xermelo 250 mg tablets (84-count) on September 9, 2025, with a ceiling value of $11,053.54 and an ultimate completion date of September 30, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen Drug...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of XERMELO 250 MG TABLET 84S. The contract has a firm fixed price of $5,526.76 and a period of performance through July 23, 2025. This contract is not designated as a set-aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, which provides...
- The federal contract award is a delivery order with a firm fixed price of $5,526.76 awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of XERMELO 250 MG TABLET 84S to the Defense Logistics Agency, a defense agency. The award has an ultimate completion date of July 28, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
- This delivery order for $9,295.70, awarded by the Defense Logistics Agency to Amerisourcebergen Drug Corporation, is for the purchase of 84 boxes of XERMELO 250 MG tablets with a completion date of November 6, 2023. The contract has a firm fixed price and will be performed in Conshohocken, Pennsylvania by Amerisourcebergen Drug Corporation's Corporate Office as the prime contractor. No set-aside designation was used for this procurement. The Defense Logistics Agency supports America's armed...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJK88Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,526.76 to AmerisourceBergen Drug Corp for Xermelo 250 mg tablets (84-count supply) on August 14, 2025, with completion targeted for September 5, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls within AmerisourceBergen Drug Corp's broader $999,999,999.00 IDC with DLA Troop Support Medical (SPE2DX) through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, maintains an extensive portfolio of federal medical supply contracts covering brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The company's federal procurement activities support critical defense health supply chain requirements serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.5k | 8/14/25 |